γ-Polyglutamic acid-coated vectors for effective and safe gene therapy

Journal of Controlled Release

Volumn 142, Issue 3, 2010, Pages 404-410

  Kurosaki, Tomoaki ^a   Kitahara, Takashi ^a   Kawakami, Shigeru ^b   Higuchi, Yuriko ^b   Yamaguchi, Ayumi ^a   Nakagawa, Hiroo ^a   Kodama, Yukinobu ^a   Hamamoto, Tomoyuki ^a   Hashida, Mitsuru ^b,c   Sasaki, Hitoshi ^a,d  

^a NAGASAKI UNIVERSITY HOSPITAL   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c KYOTO UNIVERSITY   (Japan)

^d NAGASAKI UNIVERSITY   (Japan)

Author keywords

Polyglutamic acid; Cationic liposome; Cationic polymer; Non viral gene delivery; Ternary complex

Indexed keywords

CATIONIC LIPOSOMES; CATIONIC POLYMERS; NON-VIRAL GENE DELIVERY; POLYGLUTAMIC ACIDS; TERNARY COMPLEX;

ACIDS; AMINO ACIDS; BIOACTIVITY; BIOLOGICAL ORGANS; CHLORINE COMPOUNDS; DIFFERENTIAL AMPLIFIERS; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; LIPOSOMES; NUCLEIC ACIDS; PHOSPHOLIPIDS; PLASTIC COATINGS; PROGRAMMED CONTROL SYSTEMS; VECTORS;

DYES;

ARGININE; LIPOSOME; NANOPARTICLE; PLASMID DNA; POLYARGININE; POLYGLUTAMIC ACID; POLYLYSINE; POLYMER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CLINICAL EFFECTIVENESS; COMPLEX FORMATION; CONTROLLED STUDY; CYTOTOXICITY; DRUG SAFETY; ERYTHROCYTE; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; IN VIVO STUDY; LUNG PARENCHYMA; MALE; MELANOMA B16; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NONVIRAL GENE THERAPY; PRIORITY JOURNAL; SPLEEN;

AGGLUTINATION; ANIMALS; CATIONS; CELL LINE, TUMOR; CELL SURVIVAL; DNA; DRUG CARRIERS; ERYTHROCYTES; GENE THERAPY; GENE TRANSFER TECHNIQUES; HEMOLYSIS; LIPOSOMES; MICE; MICROSCOPY, FLUORESCENCE; ORGAN SPECIFICITY; PEPTIDES; PHOTOCHEMICAL PROCESSES; PLASMIDS; POLYGLUTAMIC ACID; POLYLYSINE; TRANSFECTION;

EID: 77349087105     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2009.11.010     Document Type: Article

References (33)

1. Edelstein M.L., Abedi M.R., and Wixon J. Gene therapy clinical trials worldwide to 2007-an update. J. Gene Med. 9 (2007) 833-834
2. Hedman M., Hartikainen J., Syvänne M., Stjernvall J., Hedman A., Kivelä A., Vanninen E., Mussalo H., Kauppila E., Simula S., Närvänen O., Rantala A., Peuhkurinen K., Nieminen M.S., Laakso M., and Ylä-Herttuala S. Safety and feasibility of catheter-based local intracoronary vascular endothelial growth factor gene transfer in the prevention of postangioplasty and in-stent restenosis and in the treatment of chronic myocardial ischemia: phase II results of the Kuopio Angiogenesis Trial (KAT). Circulation 107 (2003) 2677-2683
3. Liu F., Shollenberger L.M., and Huang L. Non-immunostimulatory nonviral vectors. FASEB J. 18 (2004) 1779-1781
4. Gao X., Kim K.S., and Liu D. Nonviral gene delivery: what we know and what is next. AAPS J. 9 (2007) E92-E104
5. Hirko A., Tang F., and Hughes J.A. Cationic lipid vectors for plasmid DNA delivery. Curr. Med. Chem. 10 (2003) 1185-1193
6. Boussif O., Lezoualc'h F., Zanta M.A., Mergny M.D., Scherman D., Demeneix B., and Behr J.P. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 7297-7301
7. Matsumoto M., Kishikawa R., Kurosaki T., Nakagawa H., Ichikawa N., Hamamoto T., To H., Kitahara T., and Sasaki H. Hybrid vector including polyethylenimine and cationic lipid, DOTMA, for gene delivery. Int. J. Pharm. 363 (2008) 58-65
8. Eliyahu H., Servel N., Domb A.J., and Barenholz Y. Lipoplex-induced hemagglutination: potential involvement in intravenous gene delivery. Gene Ther. 9 (2002) 850-858
9. Dekie L., Toncheva V., Dubruel P., Chacht S.E.H., Barrett L., and Seymour L.W. Poly-L-glutamic acid derivatives as vectors for gene therapy. J. Control. Release 65 (2000) 187-202
10. Trubetskoy V.S., Wong S.C., Subbotin V., Budker V.G., Loomis A., Hagstrom J.E., and Wolff J.A. Recharging cationic DNA complexes with highly charged polyanions for in vitro and in vivo gene delivery. Gene Ther. 10 (2003) 261-271
11. Ito T., Iida-Tanaka N., and Koyama Y. Efficient in vivo gene transfection by stable DNA/PEI complexes coated by hyaluronic acid. J. Drug Target. 16 (2008) 276-281
12. Kurosaki T., Kitahara T., Fumoto S., Nishida K., Nakamura J., Niidome T., Kodama Y., Nakagawa H., To H., and Sasaki H. Ternary complexes of pDNA, polyethylenimine, and gamma-polyglutamic acid for gene delivery systems. Biomaterials 30 (2009) 2846-2853
13. Kurosaki T., Kitahara T., Teshima M., Nishida K., Nakamura J., Nakashima M., To H., Fukuchi H., Hamamoto T., and Sasaki H. Exploitation of de novo helper-lipids for effective gene delivery. J. Pharm. Pharmaceut. Sci. 11 (2008) 56-67
14. Lim Y.B., Han S.O., Kong H.U., Lee Y., Park J.S., Jeong B., and Kim S.W. Biodegradable polyester, poly[alpha-(4-aminobutyl)-L-glycolic acid], as a non-toxic gene carrier. Pharm. Res. 17 (2000) 811-816
15. Hattori Y., Suzuki S., Kawakami S., Yamashita F., and Hashida M. The role of dioleoylphosphatidylethanolamine (DOPE) in targeted gene delivery with mannosylated cationic liposomes via intravenous route. J. Control. Release 108 (2005) 484-495
16. Mitchell D.J., Kim D.T., Steinman L., Fathman C.G., and Rothbard J.B. Polyarginine enters cells more efficiently than other polycationic homopolymers. J. Pept. Res. 56 (2000) 318-325
17. Wu G.Y., and Wu C.H. Receptor-mediated in vitro gene transformation by a soluble DNA carrier system. J. Biol. Chem. 262 (1987) 4429-4432
18. Felgner P.L., Gadek T.R., Holm M., Roman R., Chan H.W., Wenz M., Northrop J.P., Ringold G.M., and Danielsen M. Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc. Natl. Acad. Sci. U. S. A. 84 (1987) 7413-7417
19. Felgner J.H., Kumar R., Sridhar C.N., Wheeler C.J., Tsai Y.J., Border R., Ramsey P., Martin M., and Felgner P.L. Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations. J. Biol. Chem. 269 (1994) 2550-2561
20. Hong K., Zheng W., Baker A., and Papahadjopoulos D. Stabilization of cationic liposome-plasmid DNA complexes by polyamines and poly(ethylene glycol)-phospholipid conjugates for efficient in vivo gene delivery. FEBS Lett. 400 (1997) 233-237
21. da Cruz M.T., Simões S., Pires P.P., Nir S., and de Lima M.C. Kinetic analysis of the initial steps involved in lipoplex-cell interactions: effect of various factors that influence transfection activity. Biochim. Biophys. Acta 1510 (2001) 136-151
22. Kircheis R., Kichler A., Wallner G., Kursa M., Ogris M., Felzmann T., Buchberger M., and Wagner E. Coupling of cell-binding ligands to polyethylenimine for targeted gene delivery. Gene Ther. 4 (1997) 409-418
23. Pouton C.W., Lucas P., Thomas B.J., Uduehi A.N., Milroy D.A., and Moss S.H. Polycation-DNA complexes for gene delivery: a comparison of the biopharmaceutical properties of cationic polypeptides and cationic lipids. J. Control. Release 53 (1998) 289-299
24. Piddubnyak V., Kurcok P., Matuszowicz A., Głowala M., Fiszer-Kierzkowska A., Jedliński Z., Juzwa M., and Krawczyk Z. Oligo-3-hydroxybutyrates as potential carriers for drug delivery. Biomaterials 25 (2004) 5271-5279
25. Itaka K., Harada A., Yamasaki Y., Nakamura K., Kawaguchi H., and Kataoka K. In situ single cell observation by fluorescence resonance energy transfer reveals fast intra-cytoplasmic delivery and easy release of plasmid DNA complexed with linear polyethylenimine. J. Gene Med. 6 (2004) 76-84
26. Merdan T., Kunath K., Fischer D., Kopecek J., and Kissel T. Intracellular processing of poly(ethylene imine)/ribozyme complexes can be observed in living cells by using confocal laser scanning microscopy and inhibitor experiments. Pharm. Res. 19 (2002) 140-146
27. Nguyen L.T., Atobe K., Barichello J.M., Ishida T., and Kiwada H. Complex formation with plasmid DNA increases the cytotoxicity of cationic liposomes. Biol. Pharm. Bull. 30 (2007) 751-757
28. Ogris M., Brunner S., Schüller S., Kircheis R., and Wagner E. PEGylated DNA/transferrin-PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery. Gene Ther. 6 (1999) 595-605
29. Ogris M., and Wagner E. Targeting tumors with non-viral gene delivery systems. Drug Discov. Today 7 (2002) 479-485
30. Cook S.E., Park I.K., Kim E.M., Jeong H.J., Park T.G., Choi Y.J., Akaike T., and Cho C.S. Galactosylated polyethylenimine-graft-poly(vinyl pyrrolidone) as a hepatocyte-targeting gene carrier. J. Control. Release 105 (2005) 151-163
31. Kircheis R., Schüller S., Brunner S., Ogris M., Heider K.H., Zauner W., and Wagner E. Polycation-based DNA complexes for tumor-targeted gene delivery in vivo. J. Gene Med. 1 (1999) 111-120
32. Sutherland M.D., Thorkildson P., Parks S.D., and Kozel T.R. In vivo fate and distribution of poly-gamma-D-glutamic acid, the capsular antigen from Bacillus anthracis. Infect. Immun. 76 (2008) 899-906
33. Sutherland M.D., and Kozel T.R. Macrophage uptake, intracellular localization, and degradation of poly-gamma-D-glutamic acid, the capsular antigen of Bacillus anthracis. Infect. Immun. 77 (2009) 532-538